Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 7/20 | 0.69 |
| ▸ | POLB | P06746 | 4/20 | 0.69 |
| ▸ | RAB9A | P51151 | 3/20 | 0.69 |
| ▸ | XBP1 | P17861 | 2/20 | 0.69 |
| ▸ | NPC1 | O15118 | 1/20 | 0.69 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.63 |
| ▸ | KDM4E | B2RXH2 | 6/20 | 0.63 |
| ▸ | MEN1 | O00255 | 5/20 | 0.63 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.63 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.63 |
| ▸ | TSHR | P16473 | 2/20 | 0.63 |
| ▸ | HPGD | P15428 | 2/20 | 0.63 |
| ▸ | LMNA | P02545 | 1/20 | 0.63 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.63 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.63 |
| ▸ | HTT | P42858 | 1/20 | 0.63 |
| ▸ | GFER | P55789 | 1/20 | 0.46 |
| ▸ | BCHE | P06276 | 2/20 | 0.45 |
| ▸ | ACHE | P22303 | 2/20 | 0.45 |
| ▸ | PNLIP | P16233 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30929792 | 0.91 | MAPT (0.69) | MAPTPOLBRAB9AXBP1NPC1 | |
| Claulansine F SCHEMBL29684000 | 0.84 | ALDH1A1 (0.61) | MAPTPOLBRAB9AXBP1NPC1 | |
| SCHEMBL29502491 | 0.83 | MAPT (0.72) | MAPTPOLBRAB9AXBP1NPC1 | |
| SCHEMBL30929796 | 0.83 | MAPT (0.65) | MAPTPOLBRAB9AXBP1NPC1 | |
| SCHEMBL31324206 | 0.82 | MAPT (0.57) | MAPTPOLBRAB9AXBP1NPC1 | |
| Grinimibine SCHEMBL4132680 | 0.82 | MAPT (1.00) | MAPTPOLBRAB9AXBP1NPC1 | |
| SCHEMBL28829841 | 0.80 | KDM4E (0.55) | MAPTPOLBRAB9AXBP1NPC1 | |
| SCHEMBL31324179 | 0.80 | MAPT (0.60) | MAPTPOLBRAB9AXBP1NPC1 | |
| Haplamine SCHEMBL257952 | 0.77 | ALDH1A1 (1.00) | MAPTPOLBRAB9AXBP1NPC1 | |
| Haplamine SCHEMBL30203195 | 0.77 | ALDH1A1 (1.00) | MAPTPOLBRAB9AXBP1NPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4647073-A1 | MURRAYA KOENIGII IN THE TREATMENT OF UPPER RESPIRATORY TRACT INFECTIONS | Nutraceutical Technology Pharma Biotech S.r.l. (IT) | 2025-11-12 | — | — | EP | claimed |
| US-20220143124-A1 | SYNERGISTIC HERBAL COMPOSITIONS FOR PREVENTION, TREATMENT OR CONTROL OF PAIN AND/OR CARTILAGE REGENERATION | LAILA NUTRACEUTICALS (IN) | 2022-05-12 | — | — | US | claimed |
| CN-122094681-A | Carbazole compounds and therapeutic use thereof in the treatment of respiratory infections | — | 2026-05-26 | — | — | CN | disclosed |
| EP-4743082-A1 | CARBAZOLE COMPOUNDS AND THEIR USE IN THERAPY, IN THE TREATMENT OF A RESPIRATORY INFECTION | UCL Business Ltd (GB) | 2026-05-20 | — | — | EP | disclosed |
| EP-4647073-A1 | MURRAYA KOENIGII IN THE TREATMENT OF UPPER RESPIRATORY TRACT INFECTIONS | Nutraceutical Technology Pharma Biotech S.r.l. (IT) | 2025-11-12 | — | — | EP | disclosed |
| WO-2025012634-A1 | CARBAZOLE COMPOUNDS AND THEIR USE IN THERAPY, IN THE TREATMENT OF A RESPIRATORY INFECTION | UCL BUSINESS LTD (GB) | 2025-01-16 | — | — | WO | disclosed |
| CN-118141926-A | Application of plant carbazole alkaloid in preparation of iron death inhibitor | 北京大学 | 2024-06-07 | — | — | CN | disclosed |
| US-20230248737-A1 | COMPOSITIONS AND METHODS FOR TREATING PSYCHIATRIC DISORDERS OR SYMPTOMS THEREOF | PSYRX LTD. (IL) | 2023-08-10 | — | — | US | disclosed |
| EP-4175643-A1 | COMPOSITIONS AND METHODS FOR TREATING PSYCHIATRIC DISORDERS OR SYMPTOMS THEREOF | Psyrx Ltd. (IL) | 2023-05-10 | — | — | EP | disclosed |
| US-20220347185-A1 | IBOGAINE FORMULATIONS | CAAMTECH INC (US) | 2022-11-03 | — | — | US | disclosed |
| US-20220143124-A1 | SYNERGISTIC HERBAL COMPOSITIONS FOR PREVENTION, TREATMENT OR CONTROL OF PAIN AND/OR CARTILAGE REGENERATION | LAILA NUTRACEUTICALS (IN) | 2022-05-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220347185-A1 | IBOGAINE FORMULATIONS | OPRK1, OPRL1, OPRD1 | MAPT 1729/4885POLB 2600/4885RAB9A 456/4885 |
| US-20220143124-A1 | SYNERGISTIC HERBAL COMPOSITIONS FOR PREVENTION, TREATMENT OR CONTROL OF PAIN AND/OR CARTILAGE REGENERATION | TNF, COL2A1, ALPI | MAPT 3513/4885POLB 1575/4885RAB9A 1526/4885 |
| US-20230248737-A1 | COMPOSITIONS AND METHODS FOR TREATING PSYCHIATRIC DISORDERS OR SYMPTOMS THEREOF | GRIN2C, HTR5A, HTR2A | MAPT 303/4885POLB 4467/4885RAB9A 720/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.